1. Home
  2. BKSY vs ACIU Comparison

BKSY vs ACIU Comparison

Compare BKSY & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$18.38

Market Cap

658.3M

Sector

Technology

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.14

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKSY
ACIU
Founded
2013
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
658.3M
213.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BKSY
ACIU
Price
$18.38
$3.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$29.00
$10.00
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$101,731,000.00
$5,482,957.00
Revenue This Year
$8.51
N/A
Revenue Next Year
$31.31
$738.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$1.43
52 Week High
$33.20
$4.00

Technical Indicators

Market Signals
Indicator
BKSY
ACIU
Relative Strength Index (RSI) 51.31 55.61
Support Level $17.73 $2.54
Resistance Level $19.80 $2.99
Average True Range (ATR) 1.31 0.29
MACD 0.49 0.03
Stochastic Oscillator 67.95 50.40

Price Performance

Historical Comparison
BKSY
ACIU

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: